Amgen (AMGN) Payables (2009 - 2026)
Amgen's quarterly Payables came in at $2.9 billion in Q1 2026, up 21.99% year-on-year from $2.4 billion in Q1 2025, and up 24.0% quarter-over-quarter from $2.4 billion in Q4 2025.
Amgen has reported Payables for 18 years, with the latest figure at $2.9 billion in Q1 2026.
- For the quarter ending Q1 2026, Payables rose 21.99% year-over-year to $2.9 billion; the trailing twelve-month figure through Mar 2026 stood at $2.9 billion (up 21.99% YoY), and the FY2025 full-year result was $2.4 billion, up 24.06% from the prior year.
- Payables for Q1 2026 stood at $2.9 billion, up from $2.4 billion in the prior quarter.
- The five-year high for Payables was $3.0 billion in Q2 2025, with the low at $1.2 billion in Q3 2022.
- Average Payables over 5 years is $1.9 billion, with a median of $1.6 billion recorded in 2024.
- Year-over-year, Payables decreased 5.92% in 2023 and soared 87.05% in 2024.
- Tracing AMGN's Payables over 5 years: stood at $1.6 billion in 2022, then rose by 1.15% to $1.6 billion in 2023, then advanced by 20.0% to $1.9 billion in 2024, then grew by 24.06% to $2.4 billion in 2025, then rose by 24.0% to $2.9 billion in 2026.
- The last three Payables figures came in at $2.9 billion (Q1 2026), $2.4 billion (Q4 2025), and $2.8 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn | 5.03 Bn |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn | 27.92 Bn |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn | 33.77 Bn |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn | 6.01 Bn |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn | 2.94 Bn |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn | 645.00 Mn |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn | 4.51 Bn |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn | 4.23 Bn |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - | 24.45 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.94 Bn |
| Dec 31, 2025 | 2.37 Bn |
| Sep 30, 2025 | 2.84 Bn |
| Jun 30, 2025 | 3.01 Bn |
| Mar 31, 2025 | 2.41 Bn |
| Dec 31, 2024 | 1.91 Bn |
| Sep 30, 2024 | 2.15 Bn |
| Jun 30, 2024 | 2.27 Bn |
| Mar 31, 2024 | 1.63 Bn |
| Dec 31, 2023 | 1.59 Bn |
| Sep 30, 2023 | 1.36 Bn |
| Jun 30, 2023 | 1.21 Bn |
| Mar 31, 2023 | 1.32 Bn |
| Dec 31, 2022 | 1.57 Bn |
| Sep 30, 2022 | 1.20 Bn |
| Jun 30, 2022 | 1.26 Bn |
| Mar 31, 2022 | 1.40 Bn |
| Dec 31, 2021 | 1.37 Bn |
| Sep 30, 2021 | 1.17 Bn |
| Jun 30, 2021 | 1.28 Bn |
| Mar 31, 2021 | 1.40 Bn |
| Dec 31, 2020 | 1.42 Bn |
| Sep 30, 2020 | 1.16 Bn |
| Jun 30, 2020 | 1.15 Bn |
| Mar 31, 2020 | 1.34 Bn |
| Dec 31, 2019 | 1.37 Bn |
| Sep 30, 2019 | 1.01 Bn |
| Jun 30, 2019 | 1.00 Bn |
| Mar 31, 2019 | 1.09 Bn |
| Dec 31, 2018 | 1.21 Bn |
| Sep 30, 2018 | 1.04 Bn |
| Jun 30, 2018 | 1.03 Bn |
| Mar 31, 2018 | 1.09 Bn |
| Dec 31, 2017 | 1.35 Bn |
| Sep 30, 2017 | 879.00 Mn |
| Jun 30, 2017 | 883.00 Mn |
| Mar 31, 2017 | 902.00 Mn |
| Dec 31, 2016 | 917.00 Mn |
| Sep 30, 2016 | 825.00 Mn |
| Jun 30, 2016 | 870.00 Mn |
| Mar 31, 2016 | 818.00 Mn |
| Dec 31, 2015 | 965.00 Mn |
| Sep 30, 2015 | 1.07 Bn |
| Jun 30, 2015 | 934.00 Mn |
| Mar 31, 2015 | 888.00 Mn |
| Dec 31, 2014 | 995.00 Mn |
| Sep 30, 2014 | 955.00 Mn |
| Jun 30, 2014 | 982.00 Mn |
| Mar 31, 2014 | 3.45 Bn |
| Dec 31, 2013 | 3.29 Bn |
| Sep 30, 2013 | 906.00 Mn |
| Jun 30, 2013 | 1.01 Bn |
| Mar 31, 2013 | 947.00 Mn |
| Dec 31, 2012 | 3.40 Bn |
| Sep 30, 2012 | 3.34 Bn |
| Dec 31, 2011 | 726.00 Mn |
| Sep 30, 2011 | 300.00 Mn |
| Mar 31, 2010 | 882.00 Mn |
| Dec 31, 2009 | 574.00 Mn |
| Sep 30, 2009 | 1.61 Bn |
| Jun 30, 2009 | 1.64 Bn |